Emgality Patient Assistance Program
Preventing migraines and cluster headaches shouldn’t drain your budget. Through manufacturer Patient Assistance Programs, eligible patients may pay a low, fixed monthly fee. The Rx Advocates handle the entire process so you can stay on treatment without financial stress.
Medically Reviewed by Dr. Conor Sheehy, PharmD, BCPS
What is the Emgality
Patient Assistance Program?
The Emgality Patient Assistance Program is created by the pharmaceutical manufacturer to help qualifying individuals obtain their medication at reduced or no cost. Coupons and savings cards might lower costs initially, but PAPs provide dependable, continuous financial support for patients requiring ongoing migraine or cluster headache prevention. The Rx Advocates assist patients by managing applications, streamlining the approval process, and keeping enrollment active in the Emgality PAP.
Eligibility Requirements
To qualify for and receive patient assistance program benefits, patients need to satisfy certain income and residency criteria. Program requirements are designed to help people experiencing financial strain and maintain medication accessibility for all who need it.
Typical requirements to qualify include:
- Individuals qualify if they earn up to $40,000 annually
- Couples qualify if they earn up to $60,000 annually
- Larger families qualify if they earn up to $100,000 annually
- U.S. residency and a valid prescription
Important: qualification criteria differ among programs. Our team reviews individual cases and walks you through the application process.
Cost of Emgality
with The Rx Advocates
The monthly service fee depends on the number
of medications you take. For example:
In addition to our monthly service fee, we charge a one-time enrollment fee of $35.
Our service is month-to-month, so if you’re not happy with it, you may cancel at any time
The Rx Advocates can help
reduce Emgality costs
The Rx Advocates partner with more than 100 United States-based pharmaceutical manufacturers’ patient assistance programs. This partnership provides access to over 800 FDA-approved medications, including Emgality and other top prescribed drugs.
We aren’t a prescription discount card, coupon service, or health insurance plan. Our team manages the entire enrollment experience by collecting required documentation, working alongside your medical provider, and submitting complete applications to manufacturers. We conduct regular status checks to confirm approvals and arrange monthly refills to maintain treatment without interruption.
If you’re considering Emgality coupons to manage medication expenses, several factors deserve attention. Patient Assistance Programs from manufacturers offer more sustainable and effective long-term solutions than coupons.
Disadvantages
of coupons
- Restrictions: Availability varies and often includes specific qualification requirements or usage limitations
- Copay Accumulators: Coupons might not count toward your insurance deductible or out-of-pocket maximum
- Expiration Dates: Time-limited validity requires constant monitoring and replacement
- Limited Coverage: Often provide only percentage discounts, leaving substantial costs remaining
Advantages of PAP
through The Rx Advocates
- Fixed Monthly Cost: Predictable pricing immune to retail market fluctuations
- No Expiration: Continued access throughout your qualification period
- Direct From Manufacturer: Consistent medication delivery straight from the source
- Broad Support: Includes over 800 FDA-approved prescription medications
Cost of Emgality vs Other Options
Comparison
(using The Rx Advocates)
$80Â / Month
30-Day Supply
(estimated retail*)
Last Updated: September 29, 2025. Actual retail prices may vary by pharmacy and location
Frequently Asked Questions
(FAQ)
About Emgality
Emgality (galcanezumab-gnlm) is a CGRP (calcitonin gene-related peptide) antibody medication. It is primarily prescribed for adults to prevent migraines and treat episodic cluster headaches.
Mechanism of action: Emgality works by binding to the CGRP protein, a key substance in the brain involved in migraines and cluster headaches. By blocking CGRP, Emgality helps prevent these conditions rather than treating active episodes.
Additional uses: Emgality is specifically approved for migraine prevention and episodic cluster headache treatment in adults. It has not been tested for use in patients under 18 years old.
Form & administration: Administered by the patient as a subcutaneous injection using a prefilled auto-injector or syringe. For migraine prevention: 240 mg initial dose, then 120 mg monthly. For cluster headaches: 300 mg at cluster period start, then monthly until period ends.
Side effects:
- Common: injection site reactions, pain at injection site.
- Serious: allergic reactions, hypersensitivity.
- Warning: not recommended for anyone allergic to galcanezumab or other Emgality ingredients; safety not established in children under 18.
Conclusion
The Rx Advocates are dedicated to helping patients access vital medications affordably. If Emgality costs are creating obstacles to your migraine or cluster headache prevention, our team can guide you through patient assistance program qualification and maintain ongoing prescription support.
Contact us today to review your information and determine if you qualify.
Other Medications We Support
